Scavenging properties of metronidazole on free oxygen radicals in a skin lipid model system

Authors: Narayanan, Sabrina1; Hünerbein, Andreas1; Getie, Melkamu2; Jäckel, Andreas2; Neubert, Reinhard H.H.3

Source: Journal of Pharmacy and Pharmacology, Volume 59, Number 8, August 2007 , pp. 1125-1130(6)

Publisher: Pharmaceutical Press

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Reactive oxygen species (ROS) play a vital role in the pathophysiology of the skin disease rosacea, a chronic, genetically-determined and UV-triggered disease, leading to facial redness and blemishes and exhibiting a deep impact on a patient's self-esteem and quality of life. ROS can cause oxidative damage to nucleic acids, sugars, proteins and lipids, thereby contributing to adverse effects on the skin. Metronidazole has been the first-line topical agent therapy for many years; nevertheless the mechanism of action is still not well understood. The therapeutic efficacy of metronidazole has been attributed to its antioxidant effects, which can involve two pathways: decreased generation of ROS within tissues or scavenging and inactivation of existing ROS. Previous investigations have shown that metronidazole reduces ROS by decreasing ROS production in cellular in-vitro systems. The aim of the following study was to demonstrate that metronidazole additionally exhibits antioxidative properties in a cell-free system, by acting as an antioxidant scavenger. A simple skin lipid model (oxidative) system and a complex skin adapted lipid system in conjunction with thiobarbituric acid (TBA) test, a quantitative assay for the detection of malondialdehyde (MDA) and therefore lipid peroxidation, were used to determine the antioxidative properties of metronidazole after UV irradiation. Results clearly show that metronidazole has antioxidative properties in a cell-free environment, acting as a free radical scavenger. Simple skin lipid model: in the presence of 10, 100 and 500 μg mL-1metronidazole the MDA concentration was reduced by 25, 36 and 49%, respectively. Complex skin lipid system: in the presence of 100 and 500 μg mL-1metronidazole the MDA concentration was reduced by 19 and 34%, respectively. The results obtained in this study and from previous publications strongly suggest that metronidazole exhibits antioxidative effects via two mechanisms: decrease in ROS production through modulation of neutrophil activity and decrease in ROS concentration by exhibiting ROS scavenging properties. The remarkable clinical efficacy of metronidazole in the treatment of rosacea is probably due to its ability to decrease ROS via different mechanisms, thereby protecting skin components from induced damage.

Document Type: Review article

DOI: 10.1211/jpp.59.8.0010

Affiliations: 1: Medical Department, Galderma Laboratorium GmbH, Georg-Glock-Str. 8, 40474 Düsseldorf, Germany 2: Institute of Pharmacy, Martin Luther University HalleWittenberg, WolfgangLangenbeck-str. 4, D-06120 Halle/Saale, Germany 3: Institute of Pharmacy, Martin Luther University HalleWittenberg, WolfgangLangenbeck-str. 4, D-06120 Halle/Saale, Germany. reinhard.neubert@ pharmazie.uni-halle.de

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$38.49 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A